Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melphalan PHP vs Best Alternative Care for Melanoma Liver Metastases
NCT00324727Phase 3Completed
- Sponsor
- Delcath Systems
- Start
- Feb 2006
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of melphalan in Ocular Melanoma and cutaneous melanoma (CM) (2 arms), sponsored by Delcath Systems. Primary endpoint: Hepatic Progression-Free Survival. Started Feb 2006; status: completed.
02
Drugs
melphalan
03
Conditions
Ocular Melanomacutaneous melanoma (CM)
Beyond the preview
Go deeper on NCT00324727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00324727.